trapidil has been researched along with Cardiac Hypertrophy in 1 studies
Trapidil: A coronary vasodilator agent.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
Excerpt | Relevance | Reference |
---|---|---|
"Trapidil has been described to improve the redox balance and cardiac conditions." | 1.48 | Trapidil improves hemodynamic, echocardiographic and redox state parameters of right ventricle in monocrotaline-induced pulmonary arterial hypertension model. ( Belló-Klein, A; Carraro, CC; Colombo, R; da Rosa Araujo, AS; de Lima-Seolin, BG; Lacerda, DS; Poletto Bonetto, JH; Schenkel, PC; Teixeira, RB; Türck, P, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Türck, P | 1 |
Lacerda, DS | 1 |
Carraro, CC | 1 |
de Lima-Seolin, BG | 1 |
Teixeira, RB | 1 |
Poletto Bonetto, JH | 1 |
Colombo, R | 1 |
Schenkel, PC | 1 |
Belló-Klein, A | 1 |
da Rosa Araujo, AS | 1 |
1 other study available for trapidil and Cardiac Hypertrophy
Article | Year |
---|---|
Trapidil improves hemodynamic, echocardiographic and redox state parameters of right ventricle in monocrotaline-induced pulmonary arterial hypertension model.
Topics: Animals; Blood Pressure; Calcium; Cardiac Catheterization; Cardiomegaly; Disease Models, Animal; Ech | 2018 |